Spire Wealth Management Eli Lilly & CO Transaction History

Spire Wealth Management

$3.13 Billion
Q4 2024

A detailed history of Spire Wealth Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Spire Wealth Management holds 32,947 shares of LLY stock, worth $28.7 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares

32,947

Previous 32,498 1.38%

Holding current value

$28.7 Million

Previous $28.8 Million 11.66%

% of portfolio

0.81%

Previous 0.98%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 24, 2025	BUY	$727.2 - $932.06 $326,512 - $418,494	449 Added 1.38%	32,947 $25.4 Million
Q3 2024 Oct 15, 2024	BUY	$772.14 - $960.02 $977,529 - $1.22 Million	1,266 Added 4.05%	32,498 $28.8 Million
Q2 2024 Jul 31, 2024	SELL	$724.87 - $909.04 $163,095 - $204,534	-225 Reduced 0.72%	31,232 $28.3 Million
Q1 2024 Apr 24, 2024	BUY	$592.2 - $792.28 $223,851 - $299,481	378 Added 1.22%	31,457 $24.5 Million
Q4 2023 Feb 06, 2024	BUY	$525.19 - $619.13 $1.16 Million - $1.36 Million	2,200 Added 7.62%	31,079 $18.1 Million
Q3 2023 Nov 08, 2023	SELL	$434.7 - $599.3 $2.43 Million - $3.34 Million	-5,579 Reduced 16.19%	28,879 $15.5 Million
Q2 2023 Aug 09, 2023	BUY	$350.74 - $468.98 $68,043 - $90,982	194 Added 0.57%	34,458 $16.2 Million
Q1 2023 May 09, 2023	BUY	$310.63 - $364.82 $421,835 - $495,425	1,358 Added 4.13%	34,264 $11.8 Million
Q4 2022 Feb 03, 2023	BUY	$321.55 - $374.67 $1.39 Million - $1.62 Million	4,319 Added 15.11%	32,906 $12 Million
Q3 2022 Nov 07, 2022	SELL	$296.48 - $337.87 $2.94 Million - $3.35 Million	-9,907 Reduced 25.74%	28,587 $9.24 Million
Q2 2022 Jul 22, 2022	BUY	$278.73 - $327.27 $8.06 Million - $9.47 Million	28,932 Added 302.57%	38,494 $12.5 Million
Q1 2022 Apr 18, 2022	SELL	$234.69 - $291.66 $1.38 Million - $1.72 Million	-5,884 Reduced 38.09%	9,562 $2.74 Million
Q4 2021 Jan 14, 2022	BUY	$224.85 - $279.04 $1.57 Million - $1.94 Million	6,961 Added 82.04%	15,446 $4.28 Million
Q3 2021 Oct 22, 2021	BUY	$221.6 - $272.71 $198,775 - $244,620	897 Added 11.82%	8,485 $1.96 Million
Q2 2021 Jul 26, 2021	SELL	$180.55 - $233.54 $1.24 Million - $1.61 Million	-6,878 Reduced 47.55%	7,588 $1.74 Million
Q1 2021 May 21, 2021	BUY	$164.32 - $212.72 $2.38 Million - $3.08 Million	14,466 New	14,466 $2.7 Million

Others Institutions Holding LLY

# of Institutions

4,282

Shares Held

757M

Call Options Held

10.2M

Put Options Held

11.4M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $826B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Spire Wealth Management with notifications on news.

Account

Spire Wealth Management Eli Lilly & CO Transaction History